AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 103 filers reported holding AVROBIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $504,989 | +85.9% | 327,915 | +14.7% | 0.00% | 0.0% |
Q2 2023 | $271,597 | -18.4% | 285,861 | -14.2% | 0.00% | 0.0% |
Q1 2023 | $332,998 | +47.0% | 332,998 | +4.8% | 0.00% | 0.0% |
Q4 2022 | $226,596 | -10.1% | 317,851 | -19.0% | 0.00% | 0.0% |
Q3 2022 | $252,000 | -42.2% | 392,624 | -17.1% | 0.00% | 0.0% |
Q2 2022 | $436,000 | -50.9% | 473,644 | -29.6% | 0.00% | -66.7% |
Q1 2022 | $888,000 | -51.1% | 672,433 | +42.5% | 0.00% | -25.0% |
Q4 2021 | $1,817,000 | -0.5% | 471,934 | +44.2% | 0.00% | 0.0% |
Q3 2021 | $1,826,000 | +69.1% | 327,248 | +169.5% | 0.00% | +100.0% |
Q2 2021 | $1,080,000 | -29.0% | 121,448 | +1.3% | 0.00% | -50.0% |
Q1 2021 | $1,521,000 | +16.8% | 119,871 | +28.4% | 0.00% | 0.0% |
Q4 2020 | $1,302,000 | +670.4% | 93,380 | +621.5% | 0.00% | +300.0% |
Q3 2020 | $169,000 | -85.3% | 12,942 | -80.4% | 0.00% | -83.3% |
Q2 2020 | $1,149,000 | +52.2% | 65,863 | +75.6% | 0.01% | +200.0% |
Q4 2019 | $755,000 | – | 37,501 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,236,123 | $21,570,000 | 14.96% |
Aisling Capital Management LP | 1,009,779 | $17,621,000 | 6.72% |
Burrage Capital Management LLC | 225,900 | $3,942,000 | 2.76% |
New Leaf Venture Partners, L.L.C. | 315,550 | $5,506,000 | 1.58% |
TANG CAPITAL MANAGEMENT LLC | 800,000 | $13,960,000 | 1.36% |
Camber Capital Management LP | 1,350,000 | $23,558,000 | 1.35% |
Parkman Healthcare Partners LLC | 190,593 | $3,326,000 | 0.94% |
Eventide Asset Management | 1,905,307 | $33,248,000 | 0.72% |
Penn Mutual Asset Management | 37,306 | $651,000 | 0.66% |
EMERALD ADVISERS, LLC | 832,474 | $14,527,000 | 0.63% |